Bxcl501
Post Operative Pain
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
12 Active assets in the Post Operative Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Assiut University | Phase 4 | BB |
NEPENTHE Ondokuz Mayıs University | Phase 4 | BB |
SUFENTANYL Hospital Central do Funchal | Phase 4 | BB |
LIDOCAINE The University of Texas Health Science Center, Houston | Phase 4 | BB |
METHADONE The Cleveland Clinic | Phase 4 | BB |
View all 17 →
Same molecule, other indications
Bxcl501 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →